The DREAM protein is associated with thyroid enlargement and nodular development

Molecular Endocrinology

Volumn 23, Issue 6, 2009, Pages 862-870

  Rivas, Marcos ^a,b   Mellström, Britt ^a,b   Torres, Begoña ^a,b   Cali, Gaetano ^c   Ferrara, Alfonso M ^c   Terracciano, Daniela ^c   Zannini, Mariastella ^c   Morreale De Escobar, Gabriella ^d   Naranjo, Jose R ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c CNR   (Italy)

^d CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALSENILIN; THYROTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GOITER; HUMAN; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; THYROID GLAND; THYROID NODULE; TRANSGENIC MOUSE;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYCLIC AMP; GOITER; HUMANS; KV CHANNEL-INTERACTING PROTEINS; MICE; MICE, TRANSGENIC; PEPTIDES; PROTEIN BINDING; RECEPTORS, THYROTROPIN; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; THYROID GLAND;

MUS MUSCULUS;

EID: 66449094399     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0466     Document Type: Article

References (58)

1. Daull P, Jeng AY, Battistini B 2007 Towards triple vasopeptidase inhibitors for the treatment of cardiovascular diseases. J Cardiovasc Pharmacol 50:247-256 (Pubitemid 47428971)
2. Mori MA, Araújo RC, Reis FC, Sgai DG, Fonseca RG, Barros CC, Merino VF, Passadore M, Barbosa AM, Ferrari B, Carayon P, Castro CH, Shimuta SI, Luz J, Bascands JL, Schanstra JP, Even PC, Oliveira SM, Bader M, Pesquero JB 2008 Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes 57:1491-1500
3. Ong KL, Wong LY, Cheung BM 2008 The role of urotensin II in the metabolic syndrome. Peptides 29:859-867
4. Xapelli S, Agasse F, Ferreira R, Silva AP, Malva JO 2006 Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide. Recent Pat CNS Drug Discov 1:315-324
5. Fujiki N, Nishino S 2007 Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy. CNS Neurol Disord Drug Targets 6:45-62 (Pubitemid 46322294)
6. Roecker AJ, Coleman PJ 2008 Orexin receptor antagonists: medicinal chemistry and therapeutic potential. Curr Top Med Chem 8:977-987
7. Taborga M, Corcoran KE, Fernandes N, Ramkissoon SH, Rameshwar P 2007 G-coupled protein receptors and breast cancer progression: potential drug targets. Mini Rev Med Chem 7:245-251 (Pubitemid 46488248)
8. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE, Schultz G 1996 The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci USA 93:116-120 (Pubitemid 26038113)
9. Allgeier A, Laugwitz KL, Van Sande J, Schultz G, Dumont JE 1997 Multiple G-protein coupling of the dog thyrotropin receptor. Mol Cell Endocrinol 127:81-90 (Pubitemid 27144085)
10. Vassart G, Dumont JE 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596-611
11. Davies TF, Ando T, Lin RY, Tomer Y, Latif R 2005 Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest 115:1972-1983 (Pubitemid 41134132)
12. Paschke R, Ludgate M 1997 The thyrotropin receptor in thyroid diseases. N Engl J Med 337:1675-1681 (Pubitemid 27510106)
13. Duprez L, Parma J, Van Sande J, Rodien P, Sabine C, Abramowicz M, Dumont JE, Vassart G 1999 Pathology of the TSH receptor. J Pediatr Endocrinol Metab 12(Suppl 1):295-302 (Pubitemid 29287988)
14. Corvilain B, Van Sande J, Dumont JE, Vassart G 2001 Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) 55:143-158 (Pubitemid 32868577)
15. Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R 2005 Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504-524 (Pubitemid 41014264)
16. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716 (Pubitemid 128506520)
17. Davies T, Marians R, Latif R 2002 The TSH receptor reveals itself. J Clin Invest 110:161-164 (Pubitemid 34787352)
18. Van Sande J, Swillens S, Gerard C, Allgeier A, Massart C, Vassart G, Dumont JE 1995 In Chinese hamster ovary K1 cells dog and human thyrotropin receptors activate both the cyclic AMP and the phosphatidylinositol 4,5-bisphosphate cascades in the presence of thyrotropin and the cyclic AMP cascade in its absence. Eur J Biochem 229:338-343
19. Chazenbalk GD, Kakinuma A, Jaume JC, McLachlan SM, Rapoport B 1996 Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells. Endocrinology 137:4586-4591 (Pubitemid 26403293)
20. Kakinuma A, Chazenbalk G, Filetti S, McLachlan SM, Rapoport B 1996 Both the 5′ and 3′ noncoding regions of the thyrotropin receptor messenger ribonucleic acid influence the level of receptor protein expression in transfected mammalian cells. Endocrinology 137:2664-2669 (Pubitemid 126425494)
21. 2+-regulated transcriptional repressor. Nature 398:80-84
22. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS, Rhodes KJ 2000 Modulation of A-type potassium channels by a family of calcium sensors. Nature 403:553-556 (Pubitemid 30082201)
23. Holmqvist MH, Cao J, Hernandez-Pineda R, Jacobson MD, Carroll KI, Sung MA, Betty M, Ge P, Gilbride KJ, Brown ME, Jurman ME, Lawson D, Silos-Santiago I, Xie Y, Covarrubias M, Rhodes KJ, Distefano PS, An WF 2002 Elimination of fast inactivation in Kv4 A-type potassium channels by an auxiliary subunit domain. Proc Natl Acad Sci USA 99:1035-1040 (Pubitemid 34106631)
24. Carrión AM, Mellström B, Naranjo JR 1998 Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element. Mol Cell Biol 18:6921-6929 (Pubitemid 28533013)
25. Ledo F, Carrión AM, Link WA, Mellström B, Naranjo JR 2000 DREAM-αCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription. Mol Cell Biol 20:9120-9126 (Pubitemid 32246101)
26. Sanz C, Mellstrom B, Link WA, Naranjo JR, Fernandez-Luna JL 2001 Interleukin 3-dependent activation of DREAM is involved in transcriptional silencing of the apoptotic Hrk gene in hematopoietic progenitor cells. EMBO J 20:2286-2292 (Pubitemid 32410597)
27. Link WA, Ledo F, Torres B, Palczewska M, Madsen TM, Savignac M, Albar JP, Mellström B, Naranjo JR 2004 Day-night changes in downstream regulatory element antagonist modulator/potassium channel interacting protein activity contribute to circadian gene expression in pineal gland. J Neurosci 24:5346-5355 (Pubitemid 38747676)
28. Ledo F, Kremer L, Mellström B, Naranjo JR 2002 Ca2+-dependent block of CREB-CBP transcription by repressor DREAM. EMBO J 21:4583-4592 (Pubitemid 34984345)
29. Rivas M, Mellström B, Naranjo JR, Santisteban P 2004 Transcriptional repressor DREAM interacts with thyroid transcription factor-1 and regulates thyroglobulin gene expression. J Biol Chem 279:33114-33122 (Pubitemid 39062955)
30. Cheng HY, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK, Wada T, Joza NA, Crackower M, Goncalves J, Sarosi I, Woodgett JR, Oliveira-dos-Santos AJ, Ikura M, van der Kooy D, Salter MW, Penninger JM 2002 DREAM is a critical transcriptional repressor for pain modulation. Cell 108:31-43 (Pubitemid 34137010)
31. Meissner W 1971 In: Werner SC, Ingbar SH, eds. Pathology of the thyroid. New York: Harper & Row
32. 2+ signalling. Nat Rev Neurosci 8:182-193
33. Siffroi-Fernandez S, Giraud A, Lanet J, Franc JL 2002 Association of the thyrotropin receptor with calnexin, calreticulin and BiP. Efects on the maturation of the receptor. Eur J Biochem 269:4930-4937 (Pubitemid 35279007)
34. Schönberger J, Bauer J, Spruss T, Weber G, Chahoud I, Eilles C, Grimm D 2000 Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med 78:102-110 (Pubitemid 30201933)
35. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR 2008 Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93:4331-4341 (Pubitemid 352789529)
36. Lee WW, Lee B, Kim SJ, Jin J, Moon DH, Lee H 2003 Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus. Oncol Rep 10:845-849
37. Savignac M, Pintado B, Gutierrez-Adan A, Palczewska M, Mellström B, Naranjo JR 2005 Transcriptional repressor DREAM regulates T-lymphocyte proliferation and cytokine gene expression. EMBO J 24:3555-3564 (Pubitemid 41509363)
38. Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R 2002 Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci USA 99:15462-15467 (Pubitemid 35407483)
39. Marians RC, Ng L, Blair HC, Unger P, Graves PN, Davies TF 2002 Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci USA 99:15776-15781 (Pubitemid 35404006)
40. Ledent C, Dumont JE, Vassart G, Parmentier M 1992 Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J 11:537-542
41. 2+ sensor protein VILIP-1 affects cGMP signalling of guanylyl cyclase B by regulating clathrin-dependent receptor recycling in hippocampal neurons. J Cell Sci 118:2495-2505
42. Ren XQ, Cheng SB, Treuil MW, Mukherjee J, Rao J, Braunewell KH, Lindstrom JM, Anand R 2005 Structural determinants of α4β2 nicotinic acetylcholine receptor trafficking. J Neurosci 25:6676-6686 (Pubitemid 40995300)
43. Lin L, Jeanclos EM, Treuil M, Braunewell KH, Gundelfinger ED, Anand R 2002 The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the α4β2 nicotinic acetylcholine receptor. J Biol Chem 277:41872-41878 (Pubitemid 35257499)
44. 2+-binding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function. Nat Neurosci 7:1079-1087
45. Shibata R, Misonou H, Campomanes CR, Anderson AE, Schrader LA, Doliveira LC, Carroll KI, Sweatt JD, Rhodes KJ, Trimmer JS 2003 A fundamental role for KChIPs in determining the molecular properties and trafficking of Kv4.2 potassium channels. J Biol Chem 278:36445-36454 (Pubitemid 37139974)
46. Iacovelli L, Sallese M, Mariggiò S, de Blasi A 1999 Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins. FASEB J 13:1-8 (Pubitemid 29038269)
47. Ruiz-Gomez A, Mellström B, Tornero D, Morato E, Savignac M, Holguin H, Aurrekoetxea K, González P, González-García C, Ceña V, Mayor Jr F, Naranjo JR 2007 G protein-coupled receptor kinase 2-mediated phosphorylation of downstream regulatory element antagonist modulator regulates membrane trafficking of Kv4.2 potassium channel. J Biol Chem 282:1205-1215 (Pubitemid 47076528)
48. Nagayama Y 2005 Animal models of Graves' hyperthyroidism. Endocr J 52:385-394 (Pubitemid 41380546)
49. Frenzel R, Krohn K, Eszlinger M, Tönjes A, Paschke R 2005 Sialylation of human thyrotropin receptor improves and prolongs its cell-surface expression. Mol Pharmacol 68:1106-1113 (Pubitemid 41345802)
50. Calebiro D, de Filippis T, Lucchi S, Covino C, Panigone S, Beck-Peccoz P, Dunlap D, Persani L 2005 Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Hum Mol Genet 14:2991-3002 (Pubitemid 41535464)
51. Lahuna O, Quellari M, Achard C, Nola S, Méduri G, Navarro C, Vitale N, Borg JP, Misrahi M 2005 Thyrotropin receptor trafficking relies on the hScrib-βPIX-GIT1-ARF6 pathway. EMBO J 24:1364-1374 (Pubitemid 40593057)
52. Neumann S, Kleinau G, Costanzi S, Moore S, Jiang JK, Raaka BM, Thomas CJ, Krause G, Gershengorn MC 2008 A low molecular weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. Endocrinology 149:5945-5950
53. Jäschke H, Neumann S, Moore S, Thomas CJ, Colson AO, Costanzi S, Kleinau G, Jiang JK, Paschke R, Raaka BM, Krause G, Gershengorn MC 2006 A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR). J Biol Chem 281:9841-9844 (Pubitemid 43864515)
54. Covic L, Gresser AL, Talavera J, Swift S, Kuliopulos A 2002 Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides. Proc Natl Acad Sci USA 99:643-648 (Pubitemid 34106565)
55. Covic L, Misra M, Badar J, Singh C, Kuliopulos A 2002 Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation. Nat Med 8:1161-1165 (Pubitemid 35175972)
56. Kaneider NC, Agarwal A, Leger AJ, Kuliopulos A 2005 Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat Med 11:661-665 (Pubitemid 40868307)
57. Ledent C, Parmentier M, Vassart G1 990 Tissue-specific expression and methylation of a thyroglobulin-chloramphenicol acetyltransferase fusion gene in transgenic mice. Proc Natl Acad Sci USA 87:6176-6180
58. Balthasar S, Samulin J, Ahlgren H, Bergelin N, Lundqvist M, Toescu EC, Eggo MC, Törnquist K 2006 Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells. Biochem J 398:547-556 (Pubitemid 44453400)